Skip to main content
Premium Trial:

Request an Annual Quote

ExonHit Extends License for Ariadne's Pathway Software

NEW YORK (GenomeWeb News) - ExonHit Therapeutics has extended its license for Ariadne’s Pathway Studio software for its research projects in alternative RNA splicing, Ariadne said today.
 
Under the agreement, ExonHit will continue to use Pathway Studio in collaborations with drug development partners.
 
The software extracts functional relationships of genes, proteins, small molecules, cell processes, and diseases from the scientific literature and presents it in a database that can be used for analysis and for validating hypotheses.
 
ExonHit’s vice president of business development, John Jaskowiak, said the company has integrated the software into its target discovery processes “in order to identify pathways of interest and to prioritize splicing events that we will explore further in our research programs.”
 
Financial terms of the agreement were not released.

The Scan

Single-Cell Sequencing Points to Embryo Mosaicism

Mosaicism may affect preimplantation genetic tests for aneuploidy, a single-cell sequencing-based analysis of almost three dozen embryos in PLOS Genetics finds.

Rett Syndrome Mouse Model Study Points to RNA Editing Possibilities

Investigators targeted MECP2 in mutant mouse models of Rett syndrome, showing in PNAS that they could restore its expression and dial down symptoms.

Investigators Find Shared, Distinct Genetic Contributors to Childhood Hodgkin Lymphoma

An association study in JAMA Network Open uncovers risk variants within and beyond the human leukocyte antigen locus.

Transcriptomic, Epigenetic Study Appears to Explain Anti-Viral Effects of TB Vaccine

Researchers report in Science Advances on an interferon signature and long-term shifts in monocyte cell DNA methylation in Bacille Calmette-Guérin-vaccinated infant samples.